Showing results (91-100 of 356) with videos related to
Sort By:
Pageof 36
Biochemical Pharmacology|November 15, 1986
Nucleic acid binding drugs--XIV. The crystal structure of 1-methyl amsacrine hydrochloride; relationships to DNA-binding ability and anti-tumour activityS Neidle, G D Webster, B C Baguley, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1993
Crystal structure of an oligonucleotide duplex containing G.G base pairs: influence of mispairing on DNA backbone conformationJ V Skelly, K J Edwards, T C Jenkins, et al.FEBS Letters|July 7, 1986
DNA sequence preferences for the anti-cancer drug mitoxanthrone and related anthraquinones revealed by DNase I footprintingK R Fox, M J Waring, J R Brown, et al.Journal of Molecular Biology|June 27, 1997
Sequence-dependent crossed helix packing in the crystal structure of a B-DNA decamer yields a detailed model for the Holliday junctionA A Wood, C M Nunn, J O Trent, et al.Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1995
Bis(acetato)amminedichloro(cyclohexylamine)platinum(IV), an orally active anticancer drugS Neidle, C F Snook, B A Murrer, et al.Nucleic Acids Research|August 11, 1990
Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agentsC A Laughton, T C Jenkins, K R Fox, et al.FEBS Letters|December 9, 1996
Non-random usage of 'degenerate' codons is related to protein three-dimensional structureA A Adzhubei, I A Adzhubei, I A Krasheninnikov, et al.Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995
Crystal structure of a DNA decamer showing a novel pseudo four-way helix-helix junctionN Spink, C M Nunn, J Vojtechovsky, et al.Journal of Biomolecular Structure & Dynamics|October 1, 1987
The influence of intercalator structure on DNA binding strength: the importance of side chain orientationW D Wilson, S Chandrasekaran, S Kusuma, et al.Journal of Medicinal Chemistry|September 11, 1998
Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicityS Venitt, C Crofton-Sleigh, M Agbandje, et al.Pageof 36